If the price and demand for raw materials rise, companies are pleased to see that
The former German Foreign Minister and Vice Chancellor Joschka Fischer has also recognised this - in politics he fought for a long time for the legalisation of hemp - and he has now entered the cannabis business, a Canadian society.
Consumption is legal in Uruguay, Canada and Holland, where only consumption, but not cultivation and sale, is permitted in Holland. Approved as a drug in Germany since March 2017, sales of cannabis are increasing. The third quarter of 2018 almost tripled sales of cannabis flowers and preparations containing cannabis compared to the prior-year quarter. In Canada, the market volume of cannabis is around six billion Can dollars, and rising.
RavenQuest BioMed - https://www.commodity-tv.net/c/search_adv/?v=298816, a Canadian cannabis company, should be among the profiteers. The latest deal from RavenQuest BioMed is an agreement with the award-winning Amsterdam cannabis seed producer Dutch Passion to exclusively sell its seeds under its own label in Canada.
Joschka Fischer, a friend of cannabis and a former opponent of nuclear power as a politician for the Greens, changed sides to the nuclear power company RWE. This did not make much use of nuclear power in Germany, but the demand for nuclear power is increasing worldwide. So there is also a lot happening with uranium as a raw material.
One year ago, the price of uranium was around 20 US dollars per pound, today it is quoted at over 28 US dollars. The USA need about 45 million pounds of uranium per year and produce only about 400,000 pounds per year itself. Uranium Energy's projects in Wyoming (largest and fully approved project in the USA) and Texas (approved for two million pounds of uranium annually) come just in time. Above all, the centrally located Uranium Energy processing plant is a big plus. The production cutbacks by competitors caused by the low price of uranium in recent years are adding to the growing imbalance in supply and demand for uranium. This should particularly benefit companies such as Uranium Energy - https://www.commodity-tv.net/c/search_adv/?v=298819.
Current corporate information and press releases from Uranium Energy (https://www.resource-capital.ch/en/companies/uranium-energy-corp.html) and Ravenquest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc.html).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: www.resource-capital.ch/en/disclaimer.html